Avalo Therapeutics, Inc. · NASDAQ:AVTX
State Street Corp reported a 5.50% stake in Avalo Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 7, 2026
State Street Corp reported a 5.50% stake in Avalo Therapeutics, Inc., 2,889,287 shares, as a passive investor on Jun 30, 2026. Filed Aug 7, 2026 (Schedule 13G).
- Stake
- 5.50%
- Shares
- 2,889,287
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 5.50% | 2,889,287 |